Floatz logo

Brimonidine

Folate Receptor-Alpha Positive

AbbVieSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Folate Receptor-Alpha Positive cohort.

Asset / SponsorPhaseRating
METHYLPREDNISOLONE ACETATE IMPURITY E
AbbVie
Phase 2CCC
Mirvetuximab Soravtansine
AbbVie
Phase 2CCC

Same molecule, other indications

Brimonidine is also rated in:

relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
65 / 100
View asset →
prostate cancerDormant
B
Indicative ·
56 / 100
View asset →
ovarian cancerDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →